DFO
MGNX icon

Duquesne Family Office’s MacroGenics MGNX Stock Holding History

Duquesne Family Office’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-472,500
Closed -$14.8M – 38
2015
Q1 		$14.8M Hold
472,500
– – 1.88% 22
2014
Q4 		$16.6M Buy
+472,500
New +$11.8M 1.62% 25

Other funds holding MGNX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
BRC
Blue Ridge Capital New York $215M AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Duquesne Family Office's MGNX Position: Q2 2015 in Review

Duquesne Family Office sold out of MacroGenics (MGNX) in Q2 2015, closing a stake of 472,500 shares — an estimated $14.8M sold.

Duquesne Family Office first reported a position in MGNX in Q4 2014 and held it in 2 quarters. The position peaked at $16.6M in Q4 2014. 128 funds tracked by Wall St. Rank hold MGNX as of Q2 2015.

  • Duquesne Family Office reported no remaining MacroGenics position as of Q2 2015 after selling out during the quarter.
  • Duquesne Family Office sold 472,500 MacroGenics shares in Q2 2015, an estimated $14.8M.
  • Duquesne Family Office first reported a position in MacroGenics in Q4 2014 and held it in 2 quarters.
  • Duquesne Family Office's MacroGenics position peaked at $16.6M in Q4 2014.
  • 128 funds tracked by Wall St. Rank held MacroGenics as of Q2 2015.

Based on Duquesne Family Office's 13F filing for Q2 2015, filed 14 Aug 2015.